1McCarroll, N, Keshava, N, Cimino, M, et al. (2008) An evaluation of the mode of action framework for mutagenic carcinogens case study: cyclophosphamide. Environ Mol Mutagen 49, 117–131.
2Haque, R, Bin-Hafeez, B, Parvez, S, et al. (2003) Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 22, 473–480.
3Bhatia, K, Kaur, M, Atif, F, et al. (2006) Aqueous extract of Trigonella foenum-graecum L. ameliorates additive urotoxicity of buthionine sulfoximine and cyclophosphamide in mice. Food Chem Toxicol 44, 1744–1750.
4Arafa, HM (2009) Uroprotective effects of curcumin in cyclophosphamide-induced haemorrhagic cystitis paradigm. Basic Clin Pharmacol Toxicol 104, 393–399.
5Anderson, D, Bishop, JB, Garner, RC, et al. (1995) Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res 330, 115–181.
6Burgaz, S, Karahalil, B, Bayrak, P, et al. (1999) Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res 439, 97–104.
7Bin-Hafeez, B, Ahmad, I, Haque, R, et al. (2001) Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice. J Ethnopharmacol 75, 13–18.
8Zandvoort, A, Lodewijk, ME, Klok, PA, et al. (2001) Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity. Clin Exp Immunol 124, 172–179.
9Angulo, I, Jimenez-Diaz, MB, Garcia-Bustos, JF, et al. (2002) Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol 218, 46–58.
10Sharma, N, Trikha, P, Athar, M, et al. (2000) Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol 19, 377–384.
11Haque, R, Bin-Hafeez, B, Ahmad, I, et al. (2001) Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol 20, 643–650.
12Shukla, Y, Arora, A & Taneja, P (2002) Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats. Mutat Res 515, 197–202.
13Ramadan, G, El-Beih, NM & Badr, GM (2006) Modulatory effects of aged garlic extract in comparison with fresh garlic extract: II – On induced immunosuppression and systemic anaphylaxis in male albino rats. Egypt J Zool 46, 265–283.
14Al-Yahya, AA, Al-Majed, AA, Gado, AM, et al. (2009) Acacia senegal gum exudate offers protection against cyclophosphamide-induced urinary bladder cytotoxicity. Oxid Med Cell Longev 2, 207–213.
15Popov, B, Georgieva, Sv & Gadjeva, V (2011) Modulatory effects of total extract of Haberlea rhodopensis against the cyclophosphamide induced genotoxicity in rabbit lymphocytes in vivo. Trakia J Sci 9, 51–57.
16Ramadan, G, El-Beih, NM & Abd El-Kareem, HF (2011) Anti-metabolic syndrome and immunostimulant activities of Egyptian fenugreek seeds in diabetic/obese and immunosuppressive rat models. Br J Nutr 105, 995–1004.
17El-Ashmawy, IM, El-Nahas, AF & Salama, OM (2005) Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana on lead acetate toxicity in mice. Basic Clin Pharmacol Toxicol 97, 238–243.
18Ghaly, IS, Said, A & Abdel-Wahhab, MA (2008) Zizyphus jujuba and Origanum majorana extracts protect against hydroquinone-induced clastogenicity. Environ Toxicol Pharmacol 25, 10–19.
19Novak, J, Bitsch, C, Langbehn, J, et al. (2000) Ratios of cis- and trans-sabinene hydrate in Origanum majorana L. and Origanum microphyllum (Bentham) vogel. Biochem Syst Ecol 28, 697–704.
20Vagi, E, Rapavi, E, Hadolin, M, et al. (2005) Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. J Agric Food Chem 53, 17–21.
21Jun, WJ, Han, BK, Yu, KW, et al. (2001) Antioxidant effects of Origanum majorana L. on superoxide anion radicals. Food Chem 75, 439–444.
22Heo, HJ, Cho, HY, Hong, B, et al. (2002) Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury. Mol Cells 13, 5–11.
23Ramadan, G, El-Beih, NM & Abd El-Ghffar, EA (2009) Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models. Br J Nutr 102, 1611–1619.
24Jayatilleke, E & Shaw, S (1993) A high-performance liquid chromatographic assay for reduced and oxidized glutathione in biological samples. Anal Biochem 214, 452–457.
25Karatepe, M (2004) Simultaneous determination of ascorbic acid and free malondialdhyde in human serum by HPLC-UV. LC GC N Am 22, 362–365.
26Johansson, LH & Borg, LA (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174, 331–336.
27Habig, WH, Pabst, MJ & Jakoby, WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249, 7130–7139.
28Paglia, DE & Valentine, WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158–169.
29Minami, M & Yoshikawa, H (1979) A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 92, 337–342.
30El-Beih, NM, Ramadan, G & Badr, GM (2006) Modulatory effects of aged garlic extract in comparison with fresh garlic extract: I – On induced liver toxicity and genotoxicity in male albino rats. Egypt J Zool 46, 245–264.
31Turner, JR & Thayer, JF (editors) (2001) Introduction to Analysis of Variance: Design, Analysis and Interpretation. Thousand Oaks, CA: Sage Publications.
32Boddy, AV & Yule, SM (2000) Metabolism and pharmacokinetics of oxazaphosphorines. Clin Pharmacokinet 38, 291–304.
33Kehrer, JP & Biswal, SS (2000) The molecular effects of acrolein. Toxicol Sci 57, 6–15.
34Hussain, SP, Hofseth, LJ & Harris, CC (2003) Radical causes of cancer. Nat Rev Cancer 3, 276–285.
35Jahangir, T, Khan, TH, Prasad, L, et al. (2005) Pluchea lanceolata attenuates cadmium chloride induced oxidative stress and genotoxicity in Swiss albino mice. J Pharm Pharmacol 57, 1199–1204.
36Lee, DH, Lim, BS, Lee, YK, et al. (2006) Involvement of oxidative stress in mutagenicity and apoptosis caused by dental resin monomers in cell cultures. Dent Mater 22, 1086–1092.
37Lin, LT, Liu, LT, Chiang, LC, et al. (2002) In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phytother Res 16, 440–444.
38Zeytinoglu, H, Incesu, Z & Baser, KH (2003) Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. Phytomedicine 10, 292–299.
39Arunasree, KM (2010) Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 17, 581–588.
40Leeja, L & Thoppil, JE (2007) Antimicrobial activity of methanol extract of Origanum majorana L. (Sweet marjoram). J Environ Biol 28, 145–146.
41Li, Z, Henning, SM, Zhang, Y, et al. (2010) Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations. Am J Clin Nutr 91, 1180–1184.
42Manesh, C & Kuttan, G (2005) Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine 12, 487–493.
43Zhong, S, Huang, M, Yang, X, et al. (2006) Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 62, 457–472.
44Aydin, S, Basaran, AA & Basaran, N (2005) Modulating effects of thyme and its major ingredients on oxidative DNA damage in human lymphocytes. J Agric Food Chem 53, 1299–1305.
45Hazzit, M, Baaliouamer, A, Faleiro, ML, et al. (2006) Composition of the essential oils of Thymus and Origanum species from Algeria and their antioxidant and antimicrobial activities. J Agric Food Chem 54, 6314–6321.
46Mythili, Y, Sudharsan, PT, Sudhahar, V, et al. (2006) Protective effect of dl-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy. Eur J Pharmacol 543, 92–96.
47Liu, X, Zhao, J & Zheng, R (2003) DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 539, 1–8.
48Berger, MM (2005) Can oxidative damage be treated nutritionally? Clin Nutr 24, 172–183.
49Borek, C (2004) Dietary antioxidants and human cancer. Integr Cancer Ther 3, 333–341.